Healthcare has consistently ranked among the top enforcement priorities for Chinese antitrust regulators, reflecting its direct implications for consumer welfare...
review
In summaryPrivate equity (PE) participation in US healthcare has accelerated over the past decade, drawing scrutiny from federal and state...
In summaryThis article delves into the latest trends in the Mexican pharmaceutical and healthcare sector from an antitrust perspective. It...
DiscussionOur findings revealed a diverse and multifaceted landscape, with significant variations in implementation, outcomes and effectiveness of social franchises across...
Healthcare Services Transactions Update – Q4 2024 Ankura is pleased to present an overview of healthcare services transactions announced or...
Healthcare workers (HCWs) with long-COVID symptoms reported that their physicians shrugged off their concerns and that they struggled to get...
